https://www.lafibreoptique.com/sante/2022-2029-strategie-de-marche-mondial-des-inhibiteurs-de-la-dipeptidyl-peptidase-4-dpp-4-par-schlusselfiguren-sanofi-takeda-eli-lilly-merck-novo-nordisk/